BE903065A - Nouvelles preparations pharmaceutiques - Google Patents

Nouvelles preparations pharmaceutiques

Info

Publication number
BE903065A
BE903065A BE1/011316A BE1011316A BE903065A BE 903065 A BE903065 A BE 903065A BE 1/011316 A BE1/011316 A BE 1/011316A BE 1011316 A BE1011316 A BE 1011316A BE 903065 A BE903065 A BE 903065A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparations
new pharmaceutical
formula
ketotifen
xanthine
Prior art date
Application number
BE1/011316A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE903065A publication Critical patent/BE903065A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE1/011316A 1984-08-16 1985-08-14 Nouvelles preparations pharmaceutiques BE903065A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH392784 1984-08-16
CH438784 1984-09-14

Publications (1)

Publication Number Publication Date
BE903065A true BE903065A (fr) 1986-02-14

Family

ID=25694194

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011316A BE903065A (fr) 1984-08-16 1985-08-14 Nouvelles preparations pharmaceutiques

Country Status (15)

Country Link
AU (1) AU4617185A (OSRAM)
BE (1) BE903065A (OSRAM)
DE (1) DE3528481A1 (OSRAM)
DK (1) DK370085A (OSRAM)
FR (1) FR2569109A1 (OSRAM)
GB (1) GB2163957A (OSRAM)
GR (1) GR851988B (OSRAM)
HU (1) HUT40568A (OSRAM)
IL (1) IL76089A0 (OSRAM)
IT (1) IT1200102B (OSRAM)
LU (1) LU86044A1 (OSRAM)
NL (1) NL8502178A (OSRAM)
PT (1) PT80961B (OSRAM)
SE (1) SE8503771L (OSRAM)
WO (1) WO1986001108A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
WO2004067006A1 (en) * 2003-01-27 2004-08-12 Pharmacia Corporation Combination of a pde iv inhibitor and a tnf-alpha antagonist
US20070042143A1 (en) 2003-04-23 2007-02-22 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
CN106913572B (zh) * 2017-04-06 2019-09-20 地奥集团成都药业股份有限公司 一种复方茶酮缓释片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound

Also Published As

Publication number Publication date
SE8503771D0 (sv) 1985-08-12
IT8548441A0 (it) 1985-08-02
WO1986001108A1 (en) 1986-02-27
GB8520189D0 (en) 1985-09-18
DE3528481A1 (de) 1986-02-27
AU4617185A (en) 1986-02-20
NL8502178A (nl) 1986-03-17
PT80961A (en) 1985-09-01
DK370085D0 (da) 1985-08-14
LU86044A1 (fr) 1986-02-18
DK370085A (da) 1986-02-17
SE8503771L (sv) 1986-02-17
GB2163957A (en) 1986-03-12
PT80961B (en) 1987-07-13
GR851988B (OSRAM) 1985-12-10
HUT40568A (en) 1987-01-28
IL76089A0 (en) 1985-12-31
IT1200102B (it) 1989-01-05
FR2569109A1 (fr) 1986-02-21

Similar Documents

Publication Publication Date Title
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
FR2615394B1 (fr) Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales
AU7197387A (en) Novel styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors, pharmaceutical compositions and methods of use therefor
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
BE903065A (fr) Nouvelles preparations pharmaceutiques
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
FR2654931B1 (fr) Compositions pharmaceutiques possedant une activite sur l'ataxie et les troubles de l'equilibre, cerebelleux ou autres, de toutes origines, comprenant l'association de l-5-hydroxytryptophane et de carbidopa.
FR2525901B1 (fr) Agent de prophylaxie et de traitement des anomalies des lipides sanguins et/ou de l'arteriosclerose, a base d'une enzyme proteolytique
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
BE894172A (fr) Compositions pour le traitement des coccidioses a base d'amidino-urees
FR2656523B1 (fr) Compositions pour l'usage cosmetique et/ou dermatologique, comprenant des pidolates metalliques.
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2666228B1 (fr) Composition pour le traitement des surcharges ponderales et/ou de la cellulite.
FR2426460A1 (fr) Composition antiallergique
BE1003340A3 (fr) Nouvelle utilisation therapeutique des alpha-aminofluorocetones.
BE881763A (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
BE904146A (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles.
BE905706A (fr) Melanges herbicides et leur utilisation pour le traitement des cultures.
FR2589716B1 (fr) Instrumentation pour le traitement des deformations rachidiennes, notamment des scolioses
FR2584605B1 (fr) Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
FR2445829A2 (fr) Methoxy-2 benzamides et leur application en therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19880831